Mobocertinib, sold under the brand name Exkivity, is used for the treatment of non-small cell lung cancer.
{{Infobox drug | image = Mobocertinib.svg | image_class = skin-invert-image | width = | alt = | caption =
| pronounce = | tradename = Exkivity | Drugs.com = | MedlinePlus = | DailyMedID = Mobocertinib | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category= Contraindicated | routes_of_administration = By mouth | class = Antineoplastic | ATC_prefix = L01 | ATC_suffix = EB10 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).